Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination
We report the case of a 19-year-old male who complained of myalgia, muscle weakness, and darkened urine two days after receiving his Ad26.COV2.S (Johnson & Johnson, New Brunswick, New Jersey, United States) COVID-19 vaccination. Blood examination revealed an increased creatine kinase (CK) level,...
Main Authors: | Georg Gelbenegger, Filippo Cacioppo, Christa Firbas, Bernd Jilma |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/9/956 |
Similar Items
-
Clinical Diagnosis of Rhabdomyolysis without Myoglobinuria or Electromyographic Abnormalities in a Dog
by: Koen Maurits Santifort, et al.
Published: (2023-05-01) -
Severe falciparum malaria with dengue coinfection complicated by rhabdomyolysis and acute kidney injury: an unusual case with myoglobinemia, myoglobinuria but normal serum creatine kinase
by: Yong Kok Pin, et al.
Published: (2012-12-01) -
Juvenile-Onset Recurrent Rhabdomyolysis Due to Compound Heterozygote Variants in the <i>ACADVL</i> Gene
by: Beatrice Labella, et al.
Published: (2023-08-01) -
Myoglobinuria-induced acute kidney injury secondary to CovishieldTM vaccination
by: Rana Fatima, et al.
Published: (2022-01-01) -
Crush syndrome
by: Emily Lovallo, et al.
Published: (2012-09-01)